BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2974053)

  • 1. Regulation of antigen-presentation-I. IFN-gamma induces antigen-presenting properties on B cells.
    Hawrylowicz CM; Unanue ER
    J Immunol; 1988 Dec; 141(12):4083-8. PubMed ID: 2974053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
    Noelle RJ; McCann J; Marshall L; Bartlett WC
    J Immunol; 1989 Sep; 143(6):1807-14. PubMed ID: 2476483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.
    Fiorentino DF; Zlotnik A; Vieira P; Mosmann TR; Howard M; Moore KW; O'Garra A
    J Immunol; 1991 May; 146(10):3444-51. PubMed ID: 1827484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction.
    Krieger JI; Chesnut RW; Grey HM
    J Immunol; 1986 Nov; 137(10):3117-23. PubMed ID: 2945857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the capacity of intact cells and purified Ia from different B cell sources to function in antigen presentation to T cells.
    Krieger J; Jenis DM; Chesnut RW; Grey HM
    J Immunol; 1988 Jan; 140(2):388-94. PubMed ID: 2961812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphokine-mediated induction of antigen-presenting ability in thymic stromal cells.
    Ransom J; Fischer M; Mercer L; Zlotnik A
    J Immunol; 1987 Oct; 139(8):2620-8. PubMed ID: 3116089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells.
    Lechler RI; Norcross MA; Germain RN
    J Immunol; 1985 Nov; 135(5):2914-22. PubMed ID: 3900200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells.
    Mond JJ; Carman J; Sarma C; Ohara J; Finkelman FD
    J Immunol; 1986 Dec; 137(11):3534-7. PubMed ID: 3097125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of antigen presentation. II. Anti-Ig and IL-2 induce IL-1 production by murine splenic B cells.
    Hawrylowicz CM; Duncan LM; Fuhlbrigge RC; Unanue ER
    J Immunol; 1989 May; 142(10):3361-8. PubMed ID: 2523925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
    Zlotnik A; Fischer M; Roehm N; Zipori D
    J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical and biochemical characterization of purified canine interferon-gamma. Production of a monoclonal antibody, affinity purification, and its effect on mixed lymphocyte culture and mixed lymphocyte kidney culture reactions.
    Fuller L; Fernandez J; Zheng S; Carreno M; Esquenazi V; Yang WC; Miller J
    Transplantation; 1992 Jan; 53(1):195-202. PubMed ID: 1531093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactive T cells in MRL/Mpr-lpr/lpr mice. Characterization of the lymphokines produced and analysis of antigen-presenting cells required.
    Weston KM; Ju ST; Lu CY; Sy MS
    J Immunol; 1988 Sep; 141(6):1941-8. PubMed ID: 3139746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantigen presentation by B cells. Requirement for IL-1 and IL-6.
    McKenzie D
    J Immunol; 1988 Nov; 141(9):2907-11. PubMed ID: 2971735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts.
    Geppert TD; Lipsky PE
    J Immunol; 1987 Jan; 138(2):385-92. PubMed ID: 3098840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation by hapten-specific B lymphocytes. V. Requirements for activation of antigen-presenting B cells.
    Liano D; Abbas AK
    J Immunol; 1987 Oct; 139(8):2562-6. PubMed ID: 2958554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid-derived epithelial cells acquire alloantigen-presenting capabilities following X-irradiation and class II antigen induction.
    Czirjak L; Danko K; Gaulton GN; Stadecker MJ
    Eur J Immunol; 1990 Dec; 20(12):2597-601. PubMed ID: 2176608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of B cells in the stimulation of syngeneic mixed lymphocyte responses.
    Thorbecke GJ; Chapman-Alexander J; Katz IR; Bienenstock A; Asofsky R
    Behring Inst Mitt; 1983 May; (72):107-16. PubMed ID: 6242330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages.
    Agrewala JN; Suvas S; Verma RK; Mishra GC
    J Immunol; 1998 Feb; 160(3):1067-77. PubMed ID: 9570518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.